Pentracor nominated for the "Zukunftspreis Brandenburg" 2021

Twelve companies have been nominated by the main jury for the "Zukunftspreis Brandenburg" 2021. Six prize winners and one company as a special prize winner will be awarded Brandenburg's most important business prize in the final on November 12 at the Airport Center Berlin Schönefeld. Pentracor GmbH, based in Hennigsdorf, is among the nominees. "We are very honored by the nomination," said Pentracor CEO Dr. Ahmed Sheriff.

2nd place for Prof. Torzewski at the GMA

He was awarded in the category 'Medical Innovation Practices & Clinics - Cardiology' for the application of the innovative CRP apheresis after myocardial infarction. He prevailed against almost all colleagues, in particular also from university hospitals and heart centers.

Project "C-reactive protein and cardiovascular diseases" was nominated for the German Medical Award

We are pleased to announce that Prof. Dr. Jan Torzewski of the Klinikum Kempten and Klinik Immenstadt from the Klinikverbund Allgäu has been nominated for the German Medical Award.

CAMI1 study was Highlight at the 85th DGK Annual Meeting


Das Poster “Selective CRP apheresis as a new treatment option in STEMI: Final results of the CAMI1 Study” von der CAMI1-Studiengruppe wurde als Highlight der DGK Jahrestagung im Bereich “Interventionelle Kardiologie” vorgestellt. 

Abstract prize at the DGfN Annual Meeting 2018


The abstract "Selective CRP apheresis as a new therapeutic option in the treatment of acute myocardial infarction (STEMI)" by Dr. Wolfgang Ries was awarded as one of the 10 best at the 10th Annual Meeting of the German Society for Nephrology (DGfN) 2018.

Poster prize at 84th Annual Meeting of DGK


The poster "Selective CRP apheresis as a new treatment option in acute myocardial infarction (CAMI1 study)" by Prof. Dr. Christoph Garlichs was awarded a poster prize at the 84th Annual Meeting of the DGK.